Nizar Touleimat1, Jörg Tost. 1. Laboratory for Epigenetics, Centre National de Génotypage, CEA-Institute de Génomique, Bâtiment G2, 2 rue Gaston Crémieux, Evry, France.
Abstract
BACKGROUND: Huge progress has been made in the development of array- or sequencing-based technologies for DNA methylation analysis. The Illumina Infinium(®) Human Methylation 450K BeadChip (Illumina Inc., CA, USA) allows the simultaneous quantitative monitoring of more than 480,000 CpG positions, enabling large-scale epigenotyping studies. However, the assay combines two different assay chemistries, which may cause a bias in the analysis if all signals are merged as a unique source of methylation measurement. MATERIALS & METHODS: We confirm in three 450K data sets that Infinium I signals are more stable and cover a wider dynamic range of methylation values than Infinium II signals. We evaluated the methylation profile of Infinium I and II probes obtained with different normalization protocols and compared these results with the methylation values of a subset of CpGs analyzed by pyrosequencing. RESULTS: We developed a subset quantile normalization approach for the processing of 450K BeadChips. The Infinium I signals were used as 'anchors' to normalize Infinium II signals at the level of probe coverage categories. Our normalization approach outperformed alternative normalization or correction approaches in terms of bias correction and methylation signal estimation. We further implemented a complete preprocessing protocol that solves most of the issues currently raised by 450K array users. CONCLUSION: We developed a complete preprocessing pipeline for 450K BeadChip data using an original subset quantile normalization approach that performs both sample normalization and efficient Infinium I/II shift correction. The scripts, being freely available from the authors, will allow researchers to concentrate on the biological analysis of data, such as the identification of DNA methylation signatures.
BACKGROUND: Huge progress has been made in the development of array- or sequencing-based technologies for DNA methylation analysis. The Illumina Infinium(®) Human Methylation 450K BeadChip (Illumina Inc., CA, USA) allows the simultaneous quantitative monitoring of more than 480,000 CpG positions, enabling large-scale epigenotyping studies. However, the assay combines two different assay chemistries, which may cause a bias in the analysis if all signals are merged as a unique source of methylation measurement. MATERIALS & METHODS: We confirm in three 450K data sets that Infinium I signals are more stable and cover a wider dynamic range of methylation values than Infinium II signals. We evaluated the methylation profile of Infinium I and II probes obtained with different normalization protocols and compared these results with the methylation values of a subset of CpGs analyzed by pyrosequencing. RESULTS: We developed a subset quantile normalization approach for the processing of 450K BeadChips. The Infinium I signals were used as 'anchors' to normalize Infinium II signals at the level of probe coverage categories. Our normalization approach outperformed alternative normalization or correction approaches in terms of bias correction and methylation signal estimation. We further implemented a complete preprocessing protocol that solves most of the issues currently raised by 450K array users. CONCLUSION: We developed a complete preprocessing pipeline for 450K BeadChip data using an original subset quantile normalization approach that performs both sample normalization and efficient Infinium I/II shift correction. The scripts, being freely available from the authors, will allow researchers to concentrate on the biological analysis of data, such as the identification of DNA methylation signatures.
Authors: Emon Elboudwarej; Michael Cole; Farren B S Briggs; Alexandra Fouts; Pamela R Fain; Hong Quach; Diana Quach; Elizabeth Sinclair; Lindsey A Criswell; Julie A Lane; Andrea K Steck; Lisa F Barcellos; Janelle A Noble Journal: J Autoimmun Date: 2016-01-09 Impact factor: 7.094
Authors: Yisong Huang; Miina Ollikainen; Maheswary Muniandy; Shaoyong Su; James Wilson; Harold Snieder; Jaakko Kaprio; Xiaoling Wang; Tao Zhang; Jenny van Dongen; Guang Hao; Peter J van der Most; Yue Pan; Natalia Pervjakova; Yan V Sun; Qin Hui; Jari Lahti; Eliza Fraszczyk; Xueling Lu; Dianjianyi Sun; Melissa A Richard; Gonneke Willemsen; Kauko Heikkila; Irene Mateo Leach; Nina Mononen; Mika Kähönen; Mikko A Hurme; Olli T Raitakari; Amanda J Drake; Markus Perola; Marja-Liisa Nuotio; Yunfeng Huang; Batbayar Khulan; Katri Räikkönen; Bruce H R Wolffenbuttel; Alexandra Zhernakova; Jingyuan Fu; Haidong Zhu; Yanbin Dong; Jana V van Vliet-Ostaptchouk; Lude Franke; Johan G Eriksson; Myriam Fornage; Lili Milani; Terho Lehtimäki; Viola Vaccarino; Dorret I Boomsma; Pim van der Harst; Eco J C de Geus; Veikko Salomaa; Shengxu Li; Wei Chen Journal: Hypertension Date: 2020-06-10 Impact factor: 10.190
Authors: Tiffany J Morris; Lee M Butcher; Andrew Feber; Andrew E Teschendorff; Ankur R Chakravarthy; Tomasz K Wojdacz; Stephan Beck Journal: Bioinformatics Date: 2013-12-12 Impact factor: 6.937
Authors: Tamar Sofer; Elizabeth D Schifano; Jane A Hoppin; Lifang Hou; Andrea A Baccarelli Journal: Bioinformatics Date: 2013-08-29 Impact factor: 6.937
Authors: Paul Yousefi; Karen Huen; Raul Aguilar Schall; Anna Decker; Emon Elboudwarej; Hong Quach; Lisa Barcellos; Nina Holland Journal: Epigenetics Date: 2013-08-19 Impact factor: 4.528
Authors: Michael C Wu; Bonnie R Joubert; Pei-fen Kuan; Siri E Håberg; Wenche Nystad; Shyamal D Peddada; Stephanie J London Journal: Epigenetics Date: 2013-11-15 Impact factor: 4.528
Authors: Ivana V Yang; Brent S Pedersen; Andrew Liu; George T O'Connor; Stephen J Teach; Meyer Kattan; Rana Tawil Misiak; Rebecca Gruchalla; Suzanne F Steinbach; Stanley J Szefler; Michelle A Gill; Agustin Calatroni; Gloria David; Corinne E Hennessy; Elizabeth J Davidson; Weiming Zhang; Peter Gergen; Alkis Togias; William W Busse; David A Schwartz Journal: J Allergy Clin Immunol Date: 2015-03-11 Impact factor: 10.793
Authors: Valentina Lo Sardo; William Ferguson; Galina A Erikson; Eric J Topol; Kristin K Baldwin; Ali Torkamani Journal: Nat Biotechnol Date: 2016-12-12 Impact factor: 54.908